Multiple Myeloma Patients Treated with Teclistamab May Benefit from IVIG Supplementation
Results of a recent study show patients with multiple myeloma undergoing teclistamab therapy may benefit from primary intravenous immune globulin supplementation, which appears to reduce the risk of high-grade infection.
New Personalized Vaccine May Treat Pancreatic Cancer
A new study published in the journal Nature found that a personalized vaccine, named autogene cevumeran, is showing promising results for treating pancreatic cancer, one of the deadliest malignancies.
Vaccine Shows Promise In Stopping Plaque Buildup in Arteries
Chinese researchers have developed a “cocktail” nanovaccine to prevent plaque from building up in the arteries, an underlying factor in heart disease, which is the leading cause of death worldwide.
Aspirin May Prevent Metastasis of Cancer
Scientists at the University of Cambridge, who have been investigating how certain common medications might hold back the movement of cancer cells, have found that daily low-dose aspirin use could curb the spread of certain cancers, including breast and prostate tumors.
COVID-19 May Increase Kawasaki Disease Risk
A recent study found there is significantly higher intravenous immune globulin (IVIG) resistance among children who contracted COVID-19 before developing Kawasaki disease (KD).
GSK’s Penmenvy Meningococcal Vaccine Approved by FDA
GSK’s Penmenvy (meningococcal groups A, B, C, W and Y vaccine) has been approved by the U.S. Food and Drug Administration (FDA) for use in individuals aged 10 through 25 years.
Diagnosing and Treating Lyme Disease
Lyme disease is a rare disease that can cause long-term damage thanks to delayed and missed diagnoses — but it may soon have a vaccine.
Lyme Disease: A Physician’s Perspective
Kristopher Paolino, MD, is an assistant professor of medicine and assistant professor of microbiology and immunology at Upstate University Hospital in Syracuse, N.Y. He previously worked for the Walter Reed Army Medical Center and the Walter Reed Army Institute of Research in Washington, D.C. His research interests include vaccine development, Lyme disease, neglected tropical diseases and malaria.
Lyme Disease: A Patient’s Perspective
A tick bite changed Joleen Larsen’s life.
Study Reveals Best Time to Get RSV Vaccine During Pregnancy
New research led by investigators at Mass General Brigham suggests vaccination closer to 32 weeks of pregnancy, rather than the current guidelines of between 32 and 36 weeks, will better protect pregnant women’s newborns against respiratory syncitial virus (RSV).
